GENEXINE, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,430 KRW | +1.42% |
|
+3.54% | -35.05% |
| 04/07 | Genexine, Inc. Appoints Jaehyun Choi as Head of R&D | CI |
| 26/06 | Genexine, Inc. signed a letter of intent to acquire EPD Biotherapeutics Inc. for KRW25.6 billion. | CI |
Quotes 5-day view
End-of-day quote Korea S.E.| 01/07/2024 | 02/07/2024 | 03/07/2024 | 04/07/2024 | 05/07/2024 | |
|---|---|---|---|---|---|
| Last | 6520 ₩ | 6530 ₩ | 6290 ₩ | 6340 ₩ | 6430 ₩ |
| Volume | 243 358 | 86 998 | 114 454 | 72 446 | 130 103 |
| Change | +4.99% | +0.15% | -3.68% | +0.79% | +1.42% |
| Opening | 6,300.00 | 6,580.00 | 6,550.00 | 6,410.00 | 6,340.00 |
| High | 6,650.00 | 6,790.00 | 6,600.00 | 6,410.00 | 6,520.00 |
| Low | 6,270.00 | 6,360.00 | 6,250.00 | 6,260.00 | 6,300.00 |
Performance
| 1 day | +1.42% | ||
| 1 week | +3.54% | ||
| Current month | +3.54% | ||
| 1 month | -12.04% | ||
| 3 months | -19.93% | ||
| 6 months | -34.12% | ||
| Current year | -35.05% | ||
| 1 year | -31.23% | ||
| 3 years | -91.15% | ||
| 5 years | -86.94% | ||
| 10 years | -71.66% |
Volumes
marketsDaily volume
130 103
Avg. Volume 20 sessions
101 459
Avg. Volume 20 sessions KRW
652 381 370.00
Avg. Volume 20 sessions USD
473 628.87
Record volume 1
11 547 141
Record volume 2
11 224 690
Record volume 3
10 625 917
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (KRW)
266 089 438 017
Capitalization (USD)
193 180 932
Net sales (KRW)
4 426 626 990
Net sales (USD)
3 213 731
Number of employees
98
Sales / Employee (KRW)
45 169 663
Sales / Employee (USD)
32 793
Free-Float
79.4 %
Free-Float capitalization (KRW)
211 595 788 202
Free-Float capitalization (USD)
153 618 542
Average Daily Capital Traded
0.25%
Highs and lows
1 week
6 250.00
6 790.00
1 month
6 190.007 220.00
Current year
6 190.0010 400.00
1 year
6 190.0012 300.00
3 years
6 190.0073 692.31
5 years
6 190.00146 384.62
10 years
6 190.00146 384.62
Indicators
Moving average 5 days
6 422.00
Moving average 20 days
6 541.00
Moving average 50 days
6 972.20
Moving average 100 days
7 624.60
Price spread / (MMA5)
-0.12%
Price spread / (MMA20)
+1.73%
Price spread / (MMA50)
+8.43%
Price spread / (MMA100)
+18.58%
STIM
RSI 9 days
45.54
RSI 14 days
41.96
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.42% | +3.54% | -35.05% | -31.23% | 19Cr | ||
| +0.89% | +1.23% | +16.61% | +40.30% | 12TCr | ||
| +0.99% | -1.60% | +17.75% | +49.36% | 11TCr | ||
| -0.42% | -1.44% | +17.23% | +15.65% | 2.59TCr | ||
| +0.29% | -0.34% | -24.11% | -25.05% | 1.93TCr | ||
| +0.98% | +0.57% | -18.56% | -31.74% | 1.62TCr | ||
| -0.64% | +3.06% | -18.47% | -22.43% | 1.56TCr | ||
| +1.12% | -2.99% | -47.75% | -39.66% | 1.46TCr | ||
| -0.90% | -3.97% | +57.35% | +39.20% | 1.43TCr | ||
| +0.67% | +1.08% | +5.62% | +48.01% | 1.4TCr | ||
| +12.90% | +4.48% | +125.88% | +252.47% | 1.13TCr | ||
| +1.12% | +6.33% | +154.29% | +284.21% | 973.25Cr | ||
| +1.97% | +2.98% | +23.82% | +66.97% | 846.32Cr | ||
| +0.85% | +4.54% | -23.05% | -32.79% | 843.97Cr | ||
| +1.21% | -0.42% | +7.83% | +55.00% | 778.87Cr | ||
| +1.64% | +0.17% | -3.40% | +35.81% | 746.27Cr | ||
| Average | +1.51% | +0.85% | +16.00% | +44.01% | ||
| Weighted average by Cap. | +1.07% | +0.23% | +16.12% | +41.11% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -35.05% | ||
| 2023 | -31.18% | ||
| 2022 | -67.92% | ||
| 2021 | -53.10% | ||
| 2020 | +98.88% | ||
| 2019 | -13.91% | ||
| 2018 | -0.55% | ||
| 2017 | +69.18% | ||
| 2016 | -8.09% | ||
| 2015 | +97.27% | ||
| 2014 | +75.00% | ||
| 2013 | +51.11% | ||
| 2012 | +14.29% | ||
| 2011 | +14.55% | ||
| 2010 | -20.06% | ||
| 2009 | -36.53% |
- Stock Market
- Equities
- A095700 Stock
- Quotes Genexine, Inc.
